The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
Dihydroisoquinolinone ID: ALA5283140
Chembl Id: CHEMBL5283140
Max Phase: Preclinical
Molecular Formula: C9H10ClN
Molecular Weight: 131.18
Associated Items:
Names and Identifiers Canonical SMILES: C1=Cc2ccccc2CN1.Cl
Standard InChI: InChI=1S/C9H9N.ClH/c1-2-4-9-7-10-6-5-8(9)3-1;/h1-6,10H,7H2;1H
Standard InChI Key: YZHKLNCWNQOYHN-UHFFFAOYSA-N
Associated Targets(Human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Topical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 131.18Molecular Weight (Monoisotopic): 131.0735AlogP: 1.76#Rotatable Bonds: ┄Polar Surface Area: 12.03Molecular Species: NEUTRALHBA: 1HBD: 1#RO5 Violations: ┄HBA (Lipinski): 1HBD (Lipinski): 1#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: 7.53CX LogP: 1.67CX LogD: 1.30Aromatic Rings: 1Heavy Atoms: 10QED Weighted: 0.57Np Likeness Score: 0.88
References 1. Zhao Y, Zhang LX, Jiang T, Long J, Ma ZY, Lu AP, Cheng Y, Cao DS.. (2020) The ups and downs of Poly(ADP-ribose) Polymerase-1 inhibitors in cancer therapy-Current progress and future direction., 203 [PMID:32717529 ] [10.1016/j.ejmech.2020.112570 ]